Evidence map›Paper›PMID 29076351›Full record

ArticleFuture medicinal chemistry2017

Activity of gallic acid and its ester derivatives in Caenorhabditis elegans and zebrafish (Danio rerio) models.

Junya de Lacorte Singulani, Liliana Scorzoni, Paulo César Gomes, Ana Carolina Nazaré, Carlos Roberto Polaquini, Luis Octávio Regasini, Ana Marisa Fusco-Almeida, Maria José Soares Mendes-Giannini

Open access · greenAbstract read
In one paragraph

Article in Future medicinal chemistry, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Peptides fromFuture microbiology · 2025
    Article
  5. Article
  6. Polyalthic Acid fromPharmaceuticals (Basel, Switzerland) · 2023
    Article
  7. Pharmaceuticals (Basel, Switzerland) · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Banana Peels: A Waste Treasure for Human Being.Evidence-based complementary and alternative medicine : eCAM · 2022
    Review
  13. Frontiers in cellular and infection microbiology · 2021
    Review
  14. Article
  15. Article
  16. In Vitro and In Vivo Anti-Plants (Basel, Switzerland) · 2019
    Article
  17. Bioactive Peptides Against Fungal Biofilms.Frontiers in microbiology · 2019
    Review
  18. Methodologies forMicrobial cell (Graz, Austria) · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Junya de Lacorte SingulaniDepartment of Clinical Analysis, School of Pharmaceutical Sciences, São Paulo State University-UNESP, Araraquara, São Paulo, Brazil.
Liliana ScorzoniDepartment of Clinical Analysis, School of Pharmaceutical Sciences, São Paulo State University-UNESP, Araraquara, São Paulo, Brazil.
Paulo César GomesDepartment of Clinical Analysis, School of Pharmaceutical Sciences, São Paulo State University-UNESP, Araraquara, São Paulo, Brazil.
Ana Carolina NazaréDepartment of Chemistry & Environmental Sciences, Institute of Biosciences, Humanities & Exact Sciences, São Paulo State University-UNESP, São José do Rio Preto, São Paulo, Brazil.
Carlos Roberto PolaquiniDepartment of Chemistry & Environmental Sciences, Institute of Biosciences, Humanities & Exact Sciences, São Paulo State University-UNESP, São José do Rio Preto, São Paulo, Brazil.
Luis Octávio RegasiniDepartment of Chemistry & Environmental Sciences, Institute of Biosciences, Humanities & Exact Sciences, São Paulo State University-UNESP, São José do Rio Preto, São Paulo, Brazil.
Ana Marisa Fusco-AlmeidaDepartment of Clinical Analysis, School of Pharmaceutical Sciences, São Paulo State University-UNESP, Araraquara, São Paulo, Brazil.
Maria José Soares Mendes-GianniniDepartment of Clinical Analysis, School of Pharmaceutical Sciences, São Paulo State University-UNESP, Araraquara, São Paulo, Brazil.
Universidade Estadual Paulista (Unesp) · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimGallic acid and its ester derivatives have shown antifungal activity in vitro. This study was performed to investigate their activity against Candida albicans and their toxicity in the animal models Caenorhabditis elegans and zebrafish embryos.

resultsThe compounds protected worms from C. albicans infection. The dodecyl gallate was the most effective. In zebrafish embryo, gallic acid and dodecyl gallate were the least toxic.

conclusionGallic acid and its ester derivatives have potential for in vivo use against C. albicans infection. The antifungal effects and toxicity of gallate esters in these alternative animal models were dependent on carbon chain length.

Indexed as

Amphotericin BAnimalsAntifungal AgentsCaenorhabditis elegansCandida albicansEstersGallic AcidHumansMolecular StructureStructure-Activity RelationshipZebrafishAmphotericin BAntifungal AgentsEstersGallic Acidalternative animal modelsantifungal developmentgallatesgallic acidinfection

Identifiers

PMID29076351
PMCPMC6077765
OpenAlexW2766116658

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.